Corticotropin-releasing factor (CRF) orchestrates the mammalian endocrine, autonomic, and behavioral stress response and has been implicated in the pathophysiology of illnesses ranging from irritable bowel syndrome to mood and anxiety disorders. CRF is produced and released from a variety of cell types, making it difficult to distinguish the specific role of CRF from other neurotransmitters with which it colocalizes. To clarify the basic biology of the CRF neuron, we must be able to manipulate selectively CRFergic cells. Here we describe a novel transgenic mouse using 3.0 kb of the CRF promoter to drive expression of Cre-recombinase (CRFp3.0Cre). Crossing CRFp3.0Cre with a fluorescent reporter strain results in Cre-dependent green fluorescent protein expression within CRF-producing cells. Thus, CRF cells can be identified for single-cell polymerase chain reaction and electrophysiological procedures. Furthermore, the CRFp3.0Cre transgenic can be combined with other available mouse strains containing a "floxed" gene of interest to allow unparalleled detailed analysis of the CRF system.
C orticotropin-releasing factor (CRF), a 41 amino acid peptide, was discovered in 1981 by Vale and colleagues for its role in activating the hypothalamic-pituitary-adrenal (HPA) axis, a primary endocrine reaction to perceived threat. CRF has since been recognized as a key coordinator of autonomic and behavioral stress-responsivity via extrahypothalamic actions in the brainstem and limbic system, respectively (1) (2) (3) (4) (5) . Although critical in the face of real threat, overactive or inappropriate activation of CRF and the stress-response systems it coordinates can have severe consequences for mental and physical health (6 -9) .
Despite its importance in adaptive and pathological stress responsivity, the inner workings of CRFergic neurons are not well understood. CRF is produced in a variety of cell types including neurons and glia (10) and is colocalized with numerous neurotransmitters and neuropeptides (11) (12) (13) (14) (15) ; this heterogeneity complicates efforts to clarify region and cell-type-specific influences of CRF. Here we describe the development of a novel transgenic mouse in which CRFergic cells can be identified and manipulated apart from neighboring cells.
Using our previously outlined method of screening promoters for cell-type-specific expression (16), we amplified 3.0 kb upstream of the translation start site for the CRF coding sequence. This 3.0-kb promoter, inserted into a lentiviral vector backbone, drives expression of Cre-recombinase (LVCRFp3.0Cre; Figure S1 in Supplement 1). Cre, a 35-kDa enzyme, recognizes 34-bp sequences known as "LoxP" sites and excises DNA flanked by LoxP sites ("floxed") via intrachromosomal recombination (17, 18) . The LVCRFp3.0Cre construct was then used to establish a transgenic mouse in which CRF-producing cells also express Cre (CRFp3.0Cre).
Crossing CRFp3.0Cre mice with fluorescent Cre-reporter strains results in expression of green fluorescent protein (GFP), permitting real-time visualization of CRFergic cells for use in single-cell polymerase chain reaction (PCR) and electrophysiologic procedures. Importantly, CRFp3.0Cre mice can also be crossed with available transgenics containing a "floxed" gene; such dual transgenics will improve our understanding of interactions between CRF and other signaling molecules within CRFergic cells under normal and pathologic conditions.
Methods and Materials

CRFp3.0Cre Vector
The CRF promoter (3.0 kb) was PCR-amplified and topo-cloned into pCR2.1-topo, (Invitrogen, Carlsbad, California) ( Figure S1 in Supplement 1). A lentivirus backbone, pCMVGFPdNhe (19) (Inder Verma, Salk Institute, La Jolla, California) was digested to remove the CMVGFP sequence. The linearized backbone was ligated to the 3.0-kb CRF promoter and to the Cre coding sequence, using T4 DNA ligase (New England Biolabs Ipswitch, Massachusetts).
CRFp3.0Cre Mouse
After preliminary tests of promoter functionality and specificity ( Figure S2 in Supplement 1), the LVCRFp3.0Cre construct was linearized, purified by electroelution, and diluted to 2 ng/L for pronuclear microinjection into FVB mouse cells by the Emory University Transgenic Core Facility. F1 offspring, PCR-positive for CRFp3.0Cre, were crossed with one of three Cre-reporter strains, denoted below as CRFp3.0Cre LacZ , CRFp3.0Cre GFP , and CRFp3.0Cre mT/mG . Procedures are approved by Emory University's Institutional Animal Care and Use Committee.
In Situ Hybridization
CRFp3.0Cre mice were sacrificed with CO 2 , brains were freshfrozen and sectioned at 20 m on a cryostat. In situ hybridization for Cre and CRF transcripts were performed on serial slides using 35 S-UTP labeled riboprobes as described previously (20) .
X-Gal Staining
CRFp3.0Cre mice were crossed with a strain containing a Floxedstop-LacZ construct in the Rosa26 locus (Rosa LacZ, Jackson Laboratories, Bar Harbor, Maine). CRFp3.0Cre
LacZ offspring were sacri-ficed with chloral hydrate and perfused. Twenty-micrometer-thick brain sections were collected in series on SuperFrostPlus slides (Fisher Scientific, Hampton, New Hampshire). Slides were rinsed in phosphate-buffered saline then incubated overnight in X-Gal solution. At least 10 CRFp3.0Cre LacZ mice were examined; their expression patterns are represented in Figure 1 .
Immunohistochemistry
CRFp3.0Cre was crossed with a fluorescent Cre-reporter strain containing cytoplasmic EGFP downstream of a floxed-stop construct (CAG-Bgeo/GFP, Jackson Laboratories #003920). Immunohistochemistry for CRF peptide was performed on offspring from these matings (CRFp3.0Cre GFP ) to verify colocalization of Cre enzymatic activity with CRF peptide.
Electrophysiology
CRFp3.0Cre GFP mice were decapitated under isoflurane anesthesia (Abbott Laboratories, North Chicago, Ilinois). Brains were placed in kynurenic acid-based artificial cerebrospinal fluid (ACSF KA ) (21) (22) (23) . Three hundred fifty micrometers coronal slices were cut, hemisected, transferred to ACSF KA , and gassed with a 95/5% oxygen/carbon dioxide mixture for 1 hour before being placed in oxygenated control ACSF; recordings began 30 min later.
Single-Cell Reverse Transcriptase-PCR
Cytoplasm was aspirated from 25 GFP-positive and eight GFP-negative cells. For each cell, cytoplasm was expelled into a microcentrifuge tube containing reverse transcription (RT) cocktail (Applied Biosystems, Foster City, California). The RT product was amplified in triplicate as previously described (24) and screened for 18 S rRNA. Only cells positive for 18 S rRNA were subjected to amplification with primers for CRF.
Specific methods for each of these procedures are included in Supplement 1.
Results and Discussion
The paramount importance of CRF in the normal and pathologic response to a threatening situation is clear, yet the inner workings of CRF-containing circuits remain poorly understood. Achieving restricted transgene expression within CRF-expressing cells in this novel CRFp3.0Cre mouse strain has the potential to expand our understanding of CRF regulation rapidly in a regionspecific manner and perhaps contribute to the identification of relevant targets within selective CRF circuits.
As the first step in characterizing this novel strain, expression of CRF transcript was compared with that of Cre in serial slices from F2 and F3-generation CRFp3.0Cre mice. In situ hybridization revealed a high degree of congruence in regional expression of these two transcripts in serial coronal slices (n ϭ 9 mice, representative images are shown in Figure 1A-1D) .
As a second step in characterizing CRFp3.0Cre mice, Cre enzymatic activity was assessed in CRFp3.0Cre mice crossed with the Rosa-LacZ strain (CRFp3.0Cre LacZ ). In these dual transgenics, the pattern of LacZ expression matched that of CRF within the central amygdala (CeA) (Figure 1E ), the bed nucleus of the stria terminals ( Figure 1E) , and the paraventricular nucleus of the hypothalamus (PVN) (Figure 1F and 1G) . A small amount of LacZ-positive cells were scattered within the cortex, consistent with the pattern of cortical CRF. There was no other concentrated LacZ expression throughout the remainder of the brain and brainstem.
Functional Cre enzymatic activity was also assessed by crossing CRFp3.0Cre mice with a Cre-reporter strain containing a membrane bound EGFP (CRFp3.0Cre mT/mG , Figure S4 in Supplement 1), as well as a reporter strain with cytoplasmic EGFP downstream of a floxed-stop construct (CRFp3.0Cre GFP ). Immunohistochemistry for CRF was performed on six slices from four CRFp3.0Cre GFP subjects using a red fluorophore-tagged secondary antibody and compared with endogenous (Cre-mediated) GFP expression. At the cellular level, CRF-like immunoreactivity colocalized with Cre-dependent GFP expression, providing firm support that the 3.0 kb CRF "mini-promoter" targets transgene expression to CRFergic cells (Figure 2) . Potential explanations for the occasional CRF-positive/GFP-negative or CRF-negative/GFPpositive cell are discussed subsequently.
In tissue from CRFp3.0Cre GFP transgenics, GFP-expressing neurons have been visualized in real time and targeted for GFP mice; Figure 3A shows a representative trace. These data demonstrate the viability of cell-type-selective promoters to label and characterize electrophysiologic properties of a subpopulation of neurons.
Given the limited quantitative nature of immunohistochemistry, single-cell PCR was our primary method to determine the sensitivity and specificity of the CRFp3.0Cre GFP transgenic line. Of eight GFP-negative cells, none contained CRF mRNA, suggesting high (Ͼ90%) specificity of GFP expression for CRFexpressing cells. Of 25 GFP-positive cells, 21 were also CRFpositive, suggesting that approximately 85% of the GFPexpressing cells contain detectable levels of CRF transcript ( Figure 3D and 3E) .
With all promoter-driven reporter transgenic mice, the main concern is specificity of reporter expression. In the immunohistochemistry experiment, at least one cell with CRF-like immunoreactivity lacks concurrent expression of GFP (arrowhead in Figure 2 ). This CRF-positive/GFP-negative cell may have recently begun to express CRF and had not had time to produce detectable levels of GFP. In the RT-PCR experiment, lack of CRF transcript in four of the GFP-expressing cells can be explained by the sensitivity and irreversibility of Cre-mediated DNA excision; after Cre-mediated excision has occurred, GFP expression is not dependent on continued activation of the CRF promoter; expression of the GFP construct will continue even if the cell no longer expresses CRF. The detection limits of the single cell RT-PCR approach could also contribute to the finding of GFP-positive/ CRF-negative cells.
To summarize, Cre expression in this novel strain exhibits extremely high regional specificity and 85% to 90% sensitivity and specificity for CRFergic cells. This is true even within the CeA, a region of dense CRF expression. Thus, we are confident that the CRFp3.0Cre mouse reliably produces Cre within CRFergic cells. Ongoing experiments using CRFp3.0Cre mice crossed with fluorescent Cre-reporters as well as other "floxed" transgenics continue to support this conjecture.
The utility of the CRFp3.0Cre strain is twofold: 1) when crossed with a Cre-reporter strain, CRF cells are easily identifiable and distinguishable from neighboring cells for the purposes of single cell mRNA isolation and RT-PCR, laser capture, fluorescence-activated cell sorting, and intracellular recording; 2) crossing CRFp3.0Cre with extant mouse strains containing "floxed" gene constructs will extend knowledge of interactions between CRF and other signaling molecules. These properties will be employed to clarify basic cellular biology of CRF-producing neurons and stress-induced alterations in CRFergic cells, which may contribute to the pathophysiologic conditions attributed to CRF overexpression. 
